Skip to main content
SpringerLink
Log in

Nutrition in inflammatory bowel disease

  • Chapter
Inflammatory Bowel Disease: From Bench to Bedside

  • 1322 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anonymous. Dietary and other risk factors of ulcerative colitis. A case control study in Japan. Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Clin Gastroenterol 1994; 19:166–71.

    Google Scholar 

  2. Anonymous. A case control study of ulcerative colitis in relation to dietary and other factors in Japan. Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Gastroenterol 1995; 30(Suppl. 8):9–12.

    Google Scholar 

  3. O’Morain C, Tobin A, Suzuki Y, O’Riordan T. Risk factors in inflammatory bowel disease. Scand J Gastroenterol (Suppl.) 1989; 170: 58–60.

    CAS  Google Scholar 

  4. Persson PG, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case control study. Epidemiology 1992; 3: 47–52.

    PubMed  CAS  Google Scholar 

  5. Probert CS, Bhakta P, Bhamra B, Jayanthi V, Mayberry JF. Diet of South Asians with inflammatory bowel disease. Arq Gastroenterol 1996; 33: 132–5.

    PubMed  CAS  Google Scholar 

  6. Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T. Pre-illness dietary factors in inflammatory bowel disease. Gut 1997; 40: 754–60.

    PubMed  CAS  Google Scholar 

  7. Russel MG, Stockbrugger RW. Epidemiology of inflammatory bowel disease: an update. Scand J Gastroenterol 1996; 31:417–27.

    PubMed  CAS  Google Scholar 

  8. Russel MG, Engels LG, Muris JW et al. Modern life in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol 1998; 10: 243–9.

    PubMed  CAS  Google Scholar 

  9. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996; 63: 741–5.

    PubMed  CAS  Google Scholar 

  10. Tragnone A, Valpiani D, Miglio F et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7: 47–51.

    PubMed  CAS  Google Scholar 

  11. Achord JL, Gunn CHJ, Jackson JF. Regional enteritis and HLA concordance in multiple siblings. Dig Dis Sci 1982; 27: 330–2.

    PubMed  CAS  Google Scholar 

  12. Roth MP, Petersen GM, McElree C, Feldman E, Rotter JL Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology 1989; 97: 900–4.

    PubMed  CAS  Google Scholar 

  13. Orholm M, Iselius L, Sorensen TI, Munkholm P, Langholz E, Binder V. Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. Br Med J 1993; 306: 20–4.

    CAS  Google Scholar 

  14. Yang H, McElree C, Roth MP, Shanahan F, Targan SR, Rotter JI. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 1993; 34: 517–24.

    PubMed  CAS  Google Scholar 

  15. Gilberts EC, Greenstein AJ, Katsel P, Harpaz N, Greenstein RJ. Molecular evidence for two forms of Crohn disease. Proc Natl Acad Sci USA 1994; 91: 12721–4.

    PubMed  CAS  Google Scholar 

  16. Plevy SE, Targan SR, Yang H, Fernandez D, Rotter JI, Toyoda H. Tumor necrosis factor microsatellites define a Crohn’s disease-associated haplotype on chromosome 6. Gastroenterology 1996; 110: 1053–60.

    PubMed  CAS  Google Scholar 

  17. Ohmen JD, Yang HY, Yamamoto KK et al. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn’s disease, but not in ulcerative colitis. Hum Mol Genet 1996; 5: 1679–83.

    PubMed  CAS  Google Scholar 

  18. Reinshagen M, Loeliger C, Kuehnl P et al. HLA class II gene frequencies in Crohn’s disease: a population based analysis in Germany. Gut 1996; 38: 538–42.

    PubMed  CAS  Google Scholar 

  19. De La Concha EG, Fernandez-Arquero M, Santa-Cruz S et al. Positive and negative associations of distinct HLA-DR2 subtypes with ulcerative colitis (UC). Clin Exp Immunol 1997; 108: 392–5.

    Google Scholar 

  20. McLeod RS, Steinhart AH, Siminovitch KA et al. Preliminary report on the Mount Sinai Hospital Inflammatory Bowel Disease Genetics Project. Dis Colon Rectum 1997; 40: 553–7.

    PubMed  CAS  Google Scholar 

  21. Mirza MM, Lee J, Teare D et al. Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromo some 16 (IBD1) to ulcerative colitis. J Med Genet 1998; 35: 218–21.

    PubMed  CAS  Google Scholar 

  22. Bouma G, Oudkerk PM, Crusius JB et al. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn’s disease (CD). Clin Exp Immunol 1997; 109: 175–9.

    PubMed  CAS  Google Scholar 

  23. Bouma G, Crusius JB, Garcia-Gonzalez MA et al. Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin Exp Immunol 1999; 115: 294–300.

    PubMed  CAS  Google Scholar 

  24. Cavanaugh JA, Callen DF, Wilson SR et al. Analysis of Australian Crohn’s disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromo some 16. Ann Hum Genet 1998; 62: 291–8.

    PubMed  CAS  Google Scholar 

  25. Papo M, Quer JC, Gutierrez C et al. Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies. Eur J Gastroenterol Hepatol 1999; 11:413–20.

    PubMed  CAS  Google Scholar 

  26. Endres S, Ghorbani R, Kelley VE et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265–71.

    Article  PubMed  CAS  Google Scholar 

  27. Kim YI. Can fish oil maintain Crohn’s disease in remission? Nutr Rev 1996; 54: 248–52.

    Article  PubMed  CAS  Google Scholar 

  28. Salomon P, Kornbluth AA, Janowitz HD. Treatment of ulcerative colitis with fish oil n-3-omega-fatty acid: an open trial. J Clin Gastroenterol 1990; 12: 157–61.

    PubMed  CAS  Google Scholar 

  29. Stenson WF, Cort D, Rodgers J et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992; 116:609–614.

    PubMed  CAS  Google Scholar 

  30. Lorenz-Meyer H, Bauer P, Nicolay C et al. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn’s disease. A randomized controlled multicenter trial. Study Group Members (German Crohn’s Disease Study Group). Scand J Gastroenterol 1996; 31: 778–85.

    PubMed  CAS  Google Scholar 

  31. Burr ML, Merrett TG. Food intolerance: a community survey. Br J Nutr 1983; 49: 217–19.

    PubMed  CAS  Google Scholar 

  32. Young E, Stoneham MD, Petruckevitch A, Barton J, Rona R. A population study of food intolerance. Lancet 1994; 343: 1127–30.

    PubMed  CAS  Google Scholar 

  33. Bischoff SC, Herrmann A, Manns MR Prevalence of adverse reactions to food in patients with gastrointestinal disease. Allergy 1996; 51: 811–18.

    PubMed  CAS  Google Scholar 

  34. Giaffer MH, Cann P, Holdsworth CD. Long-term effects of elemental and exclusion diets for Crohn’s disease. Alimen Pharmacol Ther 1991; 5: 115–25.

    Article  CAS  Google Scholar 

  35. Pearson M, Teahon K, Levi AJ, Bjarnason I. Food intolerance and Crohn’s disease. Gut 1993; 34: 783–7.

    PubMed  CAS  Google Scholar 

  36. Ballegaard M, Bjergstrom A, Brondum S, Hylander E, Jensen L, Ladefoged K. Self-reported food intolerance in chronic inflammatory bowel disease. Scand J Gastroenterol 1997; 32: 569–71.

    PubMed  CAS  Google Scholar 

  37. Dieleman LA, Heizer WD. Nutritional issues in inflammatory bowel disease. Gastroenterol Clin N Am 1998; 27: 435–51.

    CAS  Google Scholar 

  38. Han PD, Burke A, Baldassano RN, Rombeau JL, Lichtenstein GR. Nutrition and inflammatory bowel disease. Gas troenterol Clin N Am 2000; 28: 423–43.

    Google Scholar 

  39. Sturniolo GC, Mestriner C, Lecis PE et al. Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis. Scand J Gastroenterol 1998; 33: 644–9.

    PubMed  CAS  Google Scholar 

  40. Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in patients with long standing Crohn disease currently in remission. Am J Clin Nutr 1998; 67: 919–26.

    PubMed  CAS  Google Scholar 

  41. Esteve-Comas M, Nunez MC, Fernandez-Banares F et al. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease. Gut 1993; 34: 1370–3.

    PubMed  CAS  Google Scholar 

  42. Dady IM, Thomas AG, Miller V, Kelsey AJ. Inflammatory bowel disease in infancy: an increasing problem? J Pediatr Gastroenterol Nutr 1996; 23: 569–76.

    PubMed  CAS  Google Scholar 

  43. Seidman E, LeLeiko N, Ament M et al. Nutral issues in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1991; 12:424–38.

    Article  PubMed  CAS  Google Scholar 

  44. Thomas AG, Taylor F, Miller V. Dietary intake and nutritional treatment in childhood Crohn’s disease. J Pediatr Gastroenterol Nutr 1993; 17: 75–81.

    Article  PubMed  CAS  Google Scholar 

  45. Ruuska T, Savilahti E, Maki M, Ormala T, Visakorpi JK. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr 1994; 19: 175–80.

    Article  PubMed  CAS  Google Scholar 

  46. Papadopoulou A, Rawashdeh MO, Brown GA, McNeish AS, Booth IW. Remission following an elemental diet or prednisolone in Crohn’s disease. Acta Paediatr 1995; 84: 79–83.

    PubMed  CAS  Google Scholar 

  47. Polk DB, Hattner JA, Kerner JA, Jr. Improved growth and disease activity after intermittent administration of a de fined formula diet in children with Crohn’s disease. J Parent Ent Nutr 1992; 16:499–504.

    CAS  Google Scholar 

  48. Beattie RM, Schiffrin EJ, Donnet-Hughes A et al Polymeric nutrition as the primary therapy in children with small bowel Crohn’s disease. Alimen Pharmacol Ther 1994; 8: 609–15.

    Article  CAS  Google Scholar 

  49. Khoshoo V, Reifen R, Neuman MG, Griffiths A, Pencharz PB. Effect of low-and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn’s disease. J Parent Ent Nutr 1996; 20: 401–5.

    CAS  Google Scholar 

  50. Wilschanski M, Sherman P, Pencharz P, Davis L, Corey M, Griffiths A. Supplementary enteral nutrition maintains remission in paediatric Crohn’s disease. Gut 1996; 38: 543–8.

    PubMed  CAS  Google Scholar 

  51. Rossi TM, Lee PC, Young C, Tjota A. Small intestinal mucosa changes, including epithelial cell proliferative activity, of children receiving total parenteral nutrition (TPN). Dig Dis Sci 1993; 38: 1608–13.

    PubMed  CAS  Google Scholar 

  52. Hirose S, Hirata M, Azuma N, Shirai Z, Mitudome A, Oda T. Carnitine depletion during total parenteral nutrition despite oral L-carnitine supplementation. Acta Paediatr Jpn 1997; 39: 194–200.

    PubMed  CAS  Google Scholar 

  53. Gagliardi E, Brathwaite CE. Nutral implications of significant small bowel resection. N Jersey Med 1995; 92: 155–7.

    CAS  Google Scholar 

  54. Nightingale JM. The short-bowel syndrome. Eur J Gastroenterol Hepatol 1995; 7: 514–20.

    PubMed  CAS  Google Scholar 

  55. Nightingale JM, Lennard-Jones JE, Gertner DJ, Wood SR, Bartram CI. Colonic preservation reduces need for parent eral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut 1992; 33: 1493–7.

    PubMed  CAS  Google Scholar 

  56. Woolf GM, Miller C, Kurian R, Jeejeebhoy KN. Nutral absorption in short bowel syndrome. Evaluation of fluid, calorie, and divalent cation requirements. Dig Dis Sci 1987; 32: 8–15.

    PubMed  CAS  Google Scholar 

  57. Engels LG, van den Hamer CJ, van Tongeren JH. Iron, zinc, and copper balance in short bowel patients on oral nutrition. Am J Clin Nutr 1984; 40: 1038–41.

    PubMed  CAS  Google Scholar 

  58. Edes TE, Walk BE, Thornton WHJ, Fritsche KL. Essential fatty acid sufficiency does not preclude fat-soluble-vitamin deficiency in short-bowel syndrome. Am J Clin Nutr 1991; 53: 499–502.

    PubMed  CAS  Google Scholar 

  59. Someya N, Yoshida T, Haraguchi Y, Tanaka K. A case of short bowel syndrome in which remarkable amelioration of mental deterioration was achieved by administration of trace elements. Gastroenterol Jpn 1985; 20: 465–9.

    PubMed  CAS  Google Scholar 

  60. Hiroi K, Goto Y, Ishikawa J, Kida K, Matsuda H. A case of beriberi accompanying short bowel. Acta Paediatr Jpn 1995; 37: 84–7.

    PubMed  CAS  Google Scholar 

  61. Gryboski JD. Eating disorders in inflammatory bowel disease. Am J Gastroenterol 1993; 88: 293–6.

    PubMed  CAS  Google Scholar 

  62. Holaday M, Smith KE, Robertson S, Dallas J. An atypical eating disorder with Crohn’s disease in a fifteen-year-old male: a case study. Adolescence 1994; 29: 865–73.

    PubMed  CAS  Google Scholar 

  63. Mallett P, Murch S. Anorexia nervosa complicating inflammatory bowel disease. Arch Dis Childh 1990; 65: 298–300.

    PubMed  CAS  Google Scholar 

  64. Musch MW, Chang EB. Diarrhea in inflammatory bowel diseases. In: Targan SR, Shanahan F, eds. Inflammatory Bowel Disease: From Bench to Bedside. Baltimore, MD: Williams Wilkins, 1994: 239–54.

    Google Scholar 

  65. Rigaud D, Angel LA, Cerf M et al. Mechanisms of decreased food intake during weight loss in adult Crohn’s disease patients without obvious malabsorption. Am J Clin Nutr 1994; 60: 775–81.

    PubMed  CAS  Google Scholar 

  66. Muller MJ, Schmidt LU, Korber J et al. Reduced metabolic efficiency in patients with Crohn’s disease. Dig Dis Sci 1993; 38: 2001–9.

    PubMed  CAS  Google Scholar 

  67. Chan AT, Fleming CR, O’Fallon WM, Huizenga KA. Estimated versus measured basal energy requirements in patients with Crohn’s disease. Gastroenterology 1986; 91: 75–8.

    PubMed  CAS  Google Scholar 

  68. Mingrone G, Greco AV, Benedetti G et al. Increased resting lipid oxidation in Crohn’s disease. Dig Dis Sci 1996; 41: 72–6.

    PubMed  CAS  Google Scholar 

  69. Stokes MA, Hill GL. Total energy expenditure in patients with Crohn’s disease: measurement by the combined body scan technique. J Parent Ent Nutr 1993; 17: 3–7.

    CAS  Google Scholar 

  70. Kane SV, Sable K, Hanauer SB. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol 1998; 93: 1867–72.

    PubMed  CAS  Google Scholar 

  71. Annese V, Bassotti G, Napolitano G, Usai P, Andriulli A, Vantrappen G. Gastrointestinal motility disorders in patients with inactive Crohn’s disease. Scand J Gastroenterol 1997; 32:1107–17.

    PubMed  CAS  Google Scholar 

  72. Fallingborg J, Pedersen P, Jacobsen BA. Small intestinal transit time and intraluminal pH in ileocecal resected patients with Crohn’s disease. Dig Dis Sci 1998; 43: 702–5.

    PubMed  CAS  Google Scholar 

  73. McHugh K, Castonguay TW, Collins SM, Weingarten HP. Characterization of suppression of food intake following acute colon inflammation in the rat. Am J Physiol 1993; 265: R1001–5.

    PubMed  CAS  Google Scholar 

  74. Toft-Nielsen MB, Madsbad S, Hoist JJ. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. Diabetes Care 1999; 22: 1137–43.

    PubMed  CAS  Google Scholar 

  75. Koch TR, Roddy DR, Go VL. Abnormalities of fasting serum concentrations of peptide YY in the idiopathic inflammatory bowel diseases. Am J Gastroenterol 1987; 82: 321–6.

    PubMed  CAS  Google Scholar 

  76. Wiklund B, Liljeqvist L, Rokaeus A. Neurotensin increases net fluid secretion and transit rate in the small intestine of man. Reg Pept 1984; 8: 33–9.

    CAS  Google Scholar 

  77. Lavin JH, Wittert GA, Andrews J et al. Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohy drate. Am J Clin Nutr 1998; 68: 591–8.

    PubMed  CAS  Google Scholar 

  78. Woods SC, Gibbs J. The regulation of food intake by peptides. Ann NY Acad Sci 1989; 575: 236–43.

    PubMed  CAS  Google Scholar 

  79. Zimmerman J. Drug interactions in intestinal transport of folic acid and methotrexate. Further evidence for the heterogeneity of folate transport in the human small intestine. Biochem Pharmacol 1992; 44: 1839–42.

    PubMed  CAS  Google Scholar 

  80. Reid IR. Glucocorticoid osteoporosis mechanisms and management. Eur J Endocrinol 1997; 137: 209–17.

    PubMed  CAS  Google Scholar 

  81. Haave NC, Innis SM. Effects of cholestyramine feeding on tissue lipase activities and plasma fatty acids in the pregnant rat. J Dev Physiol 1989; 12: 11–14.

    PubMed  CAS  Google Scholar 

  82. Knodel LC, Talbert RL. Adverse effects of hypolipidaemic drugs. MedToxicol 1987; 2: 10–32.

    CAS  Google Scholar 

  83. Watkins DW, Khalaii R, Cassidy MM, Vahouny GV. Alterations in calcium, magnesium, iron, and zinc metabolism by dietary cholestyramine. Dig Dis Sci 1985; 30: 477–82.

    PubMed  CAS  Google Scholar 

  84. Hanauer SB, Stathopoulos G. Risk benefit assessment of drugs used in the treatment of inflammatory bowel disease. Drug Safety 1991; 6: 192–219.

    PubMed  CAS  Google Scholar 

  85. Singleton JW, Law DH, Kelley ML Jr, Mekhjian HS, Sturdevant RA. National Cooperative Crohn’s Disease Study: adverse reactions to study drugs. Gastroenterology 1979; 77: 870–82.

    PubMed  CAS  Google Scholar 

  86. Pironi L, Cornia GL, Ursitti MA et al. Evaluation of oral administration of folic and folinic acid to prevent folate deficiency in patients with inflammatory bowel disease treated with salicylazosulfapyridine. Int J Clin Pharmacol Res 1988; 8: 143–8.

    PubMed  CAS  Google Scholar 

  87. Lyoumi S, Tamion F, Petit J et al. Induction and modulation of acute-phase response by protein malnutrition in rats: comparative effect of systemic and localized inflammation on interleukin-6 and acute-phase protein synthesis. J Nutr 1998; 128: 166–74.

    PubMed  CAS  Google Scholar 

  88. Cederholm T, Wretlind B, Hellstrom K et al. Enhanced generation of interleukins 1 beta and 6 may contribute to the cachexia of chronic disease. Am J Clin Nutr 1997; 65: 876–82.

    PubMed  CAS  Google Scholar 

  89. Beisel WR. Herman Award Lecture, 1995: infection-in duced malnutrition-from cholera to cytokines. Am J Clin Nutr 1995; 62: 813–19.

    PubMed  CAS  Google Scholar 

  90. Acciuffi S, Ghosh S, Ferguson A. Strengths and limitations of the Crohn’s disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss. Aliment Pharmacol Ther 1996; 10: 321–6.

    PubMed  CAS  Google Scholar 

  91. Baert D, Wulfrank D, Burvenich P, Lagae J. Lymph loss in the bowel and severe nutritional disturbances in Crohn’s disease. J Clin Gastroenterol 1999; 29: 277–9.

    PubMed  CAS  Google Scholar 

  92. Karbach U, Ewe K, Bodenstein H. Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn’s disease. Gut 1983; 24: 718–23.

    PubMed  CAS  Google Scholar 

  93. Arvanitakis C. Abnormalities of jejunal mucosal enzymes in ulcerative colitis and Crohn’s disease. Digestion 1979; 19: 259–66.

    PubMed  CAS  Google Scholar 

  94. Bernstein CN, Ament M, Artinian L, Ridgeway J, Shanahan F. Milk tolerance in adults with ulcerative colitis. Am J Gastroenterol 1994; 89: 872–7.

    PubMed  CAS  Google Scholar 

  95. Marteau P, Messing B, Arrigoni E et al. Do patients with short-bowel syndrome need a lactose-free diet?. Nutr 1997; 13: 13–16.

    CAS  Google Scholar 

  96. Mishkin S. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am J Clin Nutr 1997; 65: 564–7.

    PubMed  CAS  Google Scholar 

  97. Ziambaras T, Rubin DC, Perlmutter DH. Regulation of sucrase-isomaltase gene expression in human intestinal epithelial cells by inflammatory cytokines. J Biol Chem 1996; 271: 1237–42.

    PubMed  CAS  Google Scholar 

  98. Saltzman JR, Russell RM. Nutral consequences of intestinal bacterial overgrowth. Compr Ther 1994; 20: 523–30.

    PubMed  CAS  Google Scholar 

  99. Hoverstad T, Bjorneklett A, Fausa O, Midtvedt T. Short-chain fatty acids in the small-bowel bacterial overgrowth syndrome. Scand J Gastroenterol 1985; 20: 492–9.

    PubMed  CAS  Google Scholar 

  100. Bjorneklett A, Fausa O, Midtvedt T. Bacterial overgrowth in jejunal and ileal disease. Scand J Gastroenterol 1983; 18: 289–98.

    PubMed  CAS  Google Scholar 

  101. Thompson JS, Quiglcy EM, Adrian TE, Path FR. Role of the ileocecal junction in the motor response to intestinal resection. J Gastrointest Surg 1998; 2: 174–85.

    PubMed  CAS  Google Scholar 

  102. Thompson JS, Quigley EM, Adrian TE. Factors affecting outcome following proximal and distal intestinal resection in the dog: an examination of the relative roles of mucosal adaptation, motility, luminal factors, and enteric peptides. Dig Dis Sci 1999; 44: 63–74.

    PubMed  CAS  Google Scholar 

  103. Riordan SM, McIver CJ, Wakefield D, Bolin TD, Duncombe VM, Thomas MC. Small intestinal bacterial over growth in the symptomatic elderly. Am J Gastroenterol 1997; 92: 47–51.

    PubMed  CAS  Google Scholar 

  104. Hauge T, Persson J, Danielsson D. Mucosal bacterial growth in the upper gastrointestinal tract in alcoholics (heavy drinkers). Digestion 1997; 58: 591–5.

    PubMed  CAS  Google Scholar 

  105. Morris TH, Sorensen SH, Turkington J, Batt RM. Diarrhoea and increased intestinal permeability in laboratory beagles associated with proximal small intestinal bacterial overgrowth. Lab Anim 1994; 28: 313–19.

    PubMed  CAS  Google Scholar 

  106. MacMahon M, Lynch M, Mullins E et al. Small intestinal bacterial overgrowth — an incidental finding? J Am Geriatr Soc 1994; 42: 146–9.

    PubMed  CAS  Google Scholar 

  107. May GR, Sutherland LR, Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn’s disease?. Gastroenterology 1993; 104: 1627–32.

    PubMed  CAS  Google Scholar 

  108. Hollander D. Permeability in Crohn’s disease: altered barrier functions in healthy relatives?. Gastroenterology 1993; 104: 1848–51.

    PubMed  CAS  Google Scholar 

  109. Riordan SM, McIver CJ, Thomas DH, Duncombe VM, Bolin TD, Thomas MC. Luminal bacteria and small-intestinal permeability. Scand J Gastroenterol 1997; 32: 556–63.

    PubMed  CAS  Google Scholar 

  110. Yamazaki Y, Fukushima T, Sugita A, Takemura H, Tsuchiya S. The medical, nutritional and surgical treatment of fistulae in Crohn’s disease. Jpn J Surg 1990; 20: 376–83.

    PubMed  CAS  Google Scholar 

  111. Dardai E, Pirityi S, Nagy L. Parenteral and enteral nutrition and the enterocutaneous fistula treatment. II. Factors influencing the outcome of treatment. Acta Chirurg Hung 1991; 32: 305–18.

    CAS  Google Scholar 

  112. Hitosugi M, Kitamura O, Takatsu A. Sudden death of a patient with Crohn’s disease. Nippon Hoigaku Zasshi (Japanese Journal of Legal Medicine) 1998; 52: 211–14.

    CAS  Google Scholar 

  113. Thompson JS. Management of the short bowel syndrome. Gastroenterology Clin N Am 1994; 23: 403–20.

    CAS  Google Scholar 

  114. Fromm H, Malavolti M. Bile acid-induced diarrhoea. Clin Gastroenterol 1986; 15: 567–82.

    PubMed  CAS  Google Scholar 

  115. Hafkenscheid JC. Influence of bile acids on the (Na+-K+)-activated-and Mg2+-activated ATPase of rat colon. Pflugers Archiv Eur J Physiol 1977; 369: 203–6.

    CAS  Google Scholar 

  116. Kirwan WO, Smith AN, Mitchell WD, Falconer JD, Eastwood MA. Bile acids and colonic motility in the rabbit and the human. Gut 1975; 16: 894–902.

    PubMed  CAS  Google Scholar 

  117. Krag B, Krag E. Regional ileitis (Crohn’s disease). II. Electrolyte and water movement in the ileum during perfusion with bile acids. Scand J Gastroenterol 1976; 11: 487–90.

    PubMed  CAS  Google Scholar 

  118. Kruis W, Haddad A, Phillips SF. Chenodeoxycholic and ursodeoxycholic acids alter motility and fluid transit in the canine ileum. Digestion 1986; 34: 185–95.

    PubMed  CAS  Google Scholar 

  119. Hofmann AF, Poley JR. Cholestyramine treatment of diarrhea associated with ileal resection. N Engl J Med 1969; 281: 397–402.

    Article  PubMed  CAS  Google Scholar 

  120. Nyhlin H, Merrick MV, Eastwood MA. Bile acid malabsorption in Crohn’s disease and indications for its assessment using SeHCAT. Gut 1994; 35: 90–3.

    PubMed  CAS  Google Scholar 

  121. Bochenek W, Rodgers JBJ, Balint JA. Effects of changes in dietary lipids on intestinal fluid loss in the short-bowel syndrome. Ann Intern Med 1970; 72: 205–13.

    PubMed  CAS  Google Scholar 

  122. Hofmann AF, Poley JR. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology 1972; 62: 918–34.

    PubMed  CAS  Google Scholar 

  123. Borgström B, Lundh G, Hofmann A. The site of absorption of conjugated bile salts in man. Gastroenterology 1963; 45: 229–38.

    Google Scholar 

  124. Barrett KE, Dharmsathaphorn K. Pharmacological aspects of therapy in inflammatory bowel diseases: antidiarrheal agents. J Clin Gastroenterol 1988; 10: 57–63.

    PubMed  CAS  Google Scholar 

  125. Read NW. Diarrhee motrice. Clin Gastroenterol 1986; 15: 657–86.

    PubMed  CAS  Google Scholar 

  126. Read NW, Miles CA, Fisher D et al. Transit of a meal through the stomach, small intestine, and colon in normal subjects and its role in the pathogenesis of diarrhea. Gastroenterology 1980; 79: 1276–82.

    PubMed  CAS  Google Scholar 

  127. Binder HJ. Pathophysiology of acute diarrhea. Am J Med 1990; 88: 2–4S.

    Google Scholar 

  128. Chang EB, Sitrin MD, Black DD. Gastrointestinal, Hepatobiliary, and Nutritional Physiology. Philadelphia, PA: Lippincott-Raven Publishers, 1996.

    Google Scholar 

  129. Kremen AJ, Linner JH, Nelson CH. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg 1954; 140: 439–48.

    PubMed  CAS  Google Scholar 

  130. Reynell P, Spray G. Small intestinal function in the rat after massive resections. Gastroenterology 1956; 31: 361–8.

    PubMed  CAS  Google Scholar 

  131. Read NW, McFarlane A, Kinsman RI et al. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 1984; 86: 274–80.

    PubMed  CAS  Google Scholar 

  132. Spiller RC, Trotman IF, Higgins BE et al. The ileal brake-inhibition of jejunal motility after ileal fat perfusion in man. Gut 1984; 25: 365–74.

    PubMed  CAS  Google Scholar 

  133. Spiller RC, Trotman IF, Adrian TE et al. Further characterisation of the’ ileal brake’ reflex in man — effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut 1988; 29: 1042–51.

    PubMed  CAS  Google Scholar 

  134. Jeejeebhoy KN. Short bowel syndrome. In: Kinney JM, Jeejeebhoy KN, Hill GL, Owen OE, eds. Nutrition and Metabolism in Patient Care. Philadelphia, PA: W.B. Saunders, 1992: 259–65.

    Google Scholar 

  135. Lin HC, Zhao XT, Reddy SN, Wang LJ, Gu Y-G. Inhibition of intestinal transit by fat depends on length of exposure to nutrient. Gastroenterology 1994; 106, A531 (Abstract).

    Google Scholar 

  136. Anonymous. Short bowel syndrome [Clinical Conference]. Gastroenterology 1979; 77: 572–9.

    Google Scholar 

  137. Lin HC, Zhao XT, Wang L. Jejunal brake: inhibition of intestinal transit by fat in the proximal small intestine. Dig DisSci 1996; 41: 326–9.

    CAS  Google Scholar 

  138. Wen J, Luque-de LE, Kost LJ, Sarr MG, Phillips SF. Duodenal motility in fasting dogs: humoral and neural pathways mediating the colonic brake. Am J Physiol 1998; 274: G192–5.

    PubMed  CAS  Google Scholar 

  139. Lin HC, Zhao XT, Wang L. Intestinal transit is more potently inhibited by fat in the distal (ileal brake) than in the proximal (jejunal brake) gut. Dig Dis Sci 1997; 42: 19–25.

    PubMed  CAS  Google Scholar 

  140. Wen J, Phillips SF, Sarr MG, Kost LJ, Hoist JJ. PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon. Am J Physiol 1995; 269: G945–52.

    PubMed  CAS  Google Scholar 

  141. Herbst F, Kamm MA, Nicholls RJ. Effects of loperamide on ileoanal pouch function. Br J Surg 1998; 85: 1428–32.

    PubMed  CAS  Google Scholar 

  142. Fonkalsrud EW, Bustorff-Silva J. Reconstruction for chronic dysfunction of ileoanal pouches. Ann Surg 1999; 229: 197–204.

    PubMed  CAS  Google Scholar 

  143. Belliveau P, Trudel J, Vasilevsky CA, Stein B, Gordon PH. Ileoanal anastomosis with reservoirs: complications and long-term results. Can J Surg 1999; 42: 345–52.

    PubMed  CAS  Google Scholar 

  144. Welsh FK, Farmery SM, MacLennan K et al. Gut barrier function in malnourished patients. Gut 1998; 42: 396–401.

    Article  PubMed  CAS  Google Scholar 

  145. Cravo M, Camilo ME, Correia JP. Nutral support in Crohn’s disease: which route? Am J Gastroenterol 1991; 86: 317–21.

    PubMed  CAS  Google Scholar 

  146. Greenberg GR. Nutral support in inflammatory bowel disease: current status and future directions. Scand J Gas troenterol (Suppl.) 1992; 192: 117–22.

    CAS  Google Scholar 

  147. Wright RA, Adler EC. Peripheral parenteral nutrition is no better than enteral nutrition in acute exacerbation of Crohn’s disease: a prospective trial. J Clin Gastroenterol 1990; 12: 396–9.

    PubMed  CAS  Google Scholar 

  148. Best WR, Becktel JM, Singleton JW, Kern F, Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 1976; 70: 439–44.

    PubMed  CAS  Google Scholar 

  149. Singleton JW. The Crohn’s Disease Activity Index is a useful tool in clinical practice of gastroenterology. Inflam Bowel Dis 1999; 5: 138.

    Article  CAS  Google Scholar 

  150. Simonis B, Heine M, Heene DL, Gladisch R. Evaluation and validation of a Crohn’s disease inflammatory activity index reflecting pattern of endoscopic severity. Scand J Gastroenterol 1998; 33: 283–8.

    PubMed  CAS  Google Scholar 

  151. Yoshida EM. The Crohn’s Disease Activity Index, its derivatives and the Inflammatory Bowel Disease Questionnaire: a review of instruments to assess Crohn’s disease. Can J Gastroenterol 1999; 13: 65–73.

    PubMed  CAS  Google Scholar 

  152. Powell-Tuck J, Bown RL, Lennard-Jones JE. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978; 13: 833–7.

    Article  PubMed  CAS  Google Scholar 

  153. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998; 43: 29–32.

    Article  PubMed  CAS  Google Scholar 

  154. Kirschner BS. Differences in the management of inflammatory bowel disease in children and adolescents compared to adults. Neth J Med 1998; 53: S13–18.

    PubMed  CAS  Google Scholar 

  155. Turnbull GK, Vallis TM. Quality of life in inflammatory bowel disease: the interaction of disease activity with psychosocial function. Am J Gastroenterol 1995; 90: 1450–4.

    PubMed  CAS  Google Scholar 

  156. Berin MC, Perdue MH. Effect of psychoneural factors on intestinal epithelial function. Can J Gastroenterol 1997; 11: 353–7.

    PubMed  CAS  Google Scholar 

  157. Talal AH, Drossman DA. Psychosocial factors in inflammatory bowel disease. Gastroenterol Clin N Am 1995; 24: 699–716.

    CAS  Google Scholar 

  158. Guyatt G, Mitchell A, Irvine EJ et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989; 96: 804–10.

    PubMed  CAS  Google Scholar 

  159. Drossman DA, Leserman J, Li ZM, Mitchell CM, Zagami EA, Patrick DL. The rating form of IBD patient concerns: a new measure of health status. Psychosom Med 1991; 53: 701–12.

    PubMed  CAS  Google Scholar 

  160. Drossman DA, Li Z, Leserman J, Patrick DL. Ulcerative colitis and Crohn’s disease health status scales for research and clinical practice. J Clin Gastroenterol 1992; 15: 1040–12.

    Google Scholar 

  161. Johnston KR, Govel LA, Andritz MH. Gastrointestinal effects of sorbitol as an additive in liquid medications. Am J Med 1994; 97: 185–91.

    PubMed  CAS  Google Scholar 

  162. Breitenbach RA, Simon J. Cases from the aerospace medicine resident teaching file. Case 59. A case of ‘unbearable’ gremlinenteritis [Clinical Conference]. Aviat Space Environ Med 1994; 65: 432–3.

    PubMed  CAS  Google Scholar 

  163. Goldberg LD, Ditchek NT. Chewing gum diarrhea. Am J Dig Dis 1978; 23: 568.

    PubMed  CAS  Google Scholar 

  164. Lin HC, Sanders SL, Gu YG, Doty JE. Erythromycin accelerates solid emptying at the expense of gastric sieving. Dig Dis Sci 1994; 39: 124–8.

    PubMed  CAS  Google Scholar 

  165. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993; 328: 246–52.

    PubMed  CAS  Google Scholar 

  166. Borins M. The dangers of using herbs. What your patients need to know. Postgrad Med 1999; 104: 91–5.

    Google Scholar 

  167. Foster S, Tyler VE. Tyler’s Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies. 4th edn. Binghamton, NY: Haworth Press, Inc., 1999.

    Google Scholar 

  168. Wright RA, Heymsfield S. Nutral Assessment. Boston: Blackwell Scientific Publications, 1984.

    Google Scholar 

  169. Bates CJ. Diagnosis and detection of vitamin deficiencies. Br Med Bull 1999; 55: 643–57.

    PubMed  CAS  Google Scholar 

  170. Balint JP. Physical findings in nutritional deficiencies. Pediatr Clin N Am 1998; 45: 245–60.

    CAS  Google Scholar 

  171. Touger-Decker R. Oral manifestations of nutrient deficiencies. Mount Sinai J Med 1998; 65: 355–61.

    CAS  Google Scholar 

  172. Ehrenpreis ED, Popovich TL, Cravero R. A practical guide to the recognition of nutritional deficiencies. Compr Ther 1997; 23: 218–22.

    PubMed  CAS  Google Scholar 

  173. Ovesen L, Chu R, Howard L. The influence of dietary fat on jejunostomy output in patients with severe short bowel syndrome. Am J Clin Nutr 1983; 38: 270–7.

    PubMed  CAS  Google Scholar 

  174. Hylander E, Ladefoged K, Jarnum S. Calcium absorption after intestinal resection. The importance of a preserved colon. Scand J Gastroenterol 1990; 25: 705–10.

    PubMed  CAS  Google Scholar 

  175. Pigot F, Roux C, Chaussade S et al. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 1992; 37: 1396–403.

    PubMed  CAS  Google Scholar 

  176. Silvennoinen J, Lamberg-Allardt C, Karkkainen M, Nieme-la S, Lehtola J. Dietary calcium intake and its relation to bone mineral density in patients with inflammatory bowel disease. J Intern Med 1996; 240: 285–92.

    PubMed  CAS  Google Scholar 

  177. Robinson RJ, al-Azzawi F, Iqbal SJ, Kryswcki T, Almond L, Abrams K et al. Osteoporosis and determinants of bone density in patients with Crohn’s disease. Dig Dis Sci 1998; 43: 2500–6.

    PubMed  CAS  Google Scholar 

  178. Kuczera M, Wiecek A, Kokot F. Markers of bone turnover in patients with nephrolithiasis. Int Urol Nephrol 1997; 29: 523–8.

    PubMed  CAS  Google Scholar 

  179. Staniforth DH, Rose D. Statistical analysis of the lactulose/ breath hydrogen test in the measurement of orocaecal transit: its variability and predictive value in assessing drug action. Gut 1989; 30: 171–5.

    PubMed  CAS  Google Scholar 

  180. Riordan SM, Mclver CJ, Walker BM, Duncombe VM, Bolin TD, Thomas MC. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996; 91: 1795–803.

    PubMed  CAS  Google Scholar 

  181. Miller MA, Parkman HP, Urbain JL et al. Comparison of scintigraphy and lactulose breath hydrogen test for assessment of orocecal transit: lactulose accelerates small bowel transit. Dig Dis Sci 1997; 42: 10–18.

    PubMed  CAS  Google Scholar 

  182. Attar A, Flourie B, Rambaud JC et al. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology 1999; 117: 794–7.

    PubMed  CAS  Google Scholar 

  183. Sellin JH, Hart R. Glucose malabsorption associated with rapid intestinal transit. Am J Gastroenterol 1992; 87: 584–9.

    PubMed  CAS  Google Scholar 

  184. de BD, Chaussain M, Badoual J, Raymond J, Dupont C. Small-bowel bacterial overgrowth in children with chronic diarrhea, abdominal pain, or both. J Pediatr 1996; 128: 203–7.

    Google Scholar 

  185. Greenberg GR, Fleming CR, Jeejcebhoy KN, Rosenberg IH, Sales D, Tremaine WJ. Controlled trial of bowel rest and nutritional support in the management of Crohn’s disease. Gut 1988; 29: 1309–15.

    PubMed  CAS  Google Scholar 

  186. Sitzmann JV, Converse RLJ, Bayless TM. Favorable response to parentcral nutrition and medical therapy in Crohn’s colitis. A report of 38 patients comparing severe Crohn’s and ulcerative colitis. Gastroenterology 1990; 99: 1647–52.

    PubMed  CAS  Google Scholar 

  187. Reynolds JV, Kanwar S, Welsh FK et al. 1997 Harry M. Vars Research Award. Does the route of feeding modify gut barrier function and clinical outcome in patients after major upper gastrointestinal surgery? J Parent Ent Nutr 1997; 21: 196–201.

    CAS  Google Scholar 

  188. Steffes C, Fromm D. Is preoperative parenteral nutrition necessary for patients with predominantly ileal Crohn’s disease? Arch Surg 1992; 127: 1210–12.

    PubMed  CAS  Google Scholar 

  189. Carlson GL, Gray P, Barber D, Shaffer JL, Mughal M, Irving MH. Total parenteral nutrition modifies the acute phase response to Crohn’s disease. J Roy Coll Surg Edinb 1994; 39:360–4.

    PubMed  CAS  Google Scholar 

  190. Mukau L, Talamini MA, Sitzmann JV. Elemental diets may accelerate recovery from total parenteral nutrition-induced gut atrophy. J Parent Ent Nutr 1994; 18: 75–8.

    CAS  Google Scholar 

  191. Kaufman SS, Loseke CA, Lupo JV et al. Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome. J Pediatr 1997; 131: 356–61.

    PubMed  CAS  Google Scholar 

  192. Weber TR. Enteral feeding increases sepsis in infants with short bowel syndrome. J Pediatr Surg 1995; 30: 1086–8.

    PubMed  CAS  Google Scholar 

  193. Pappo I, Bercovier H, Berry E, Gallilly R, Feigin E, Freund HR. Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat. J Parent Ent Nutr 1995; 19: 80–2.

    CAS  Google Scholar 

  194. Eisenberg JM, Glick HA, Buzby GP, Kinosian B, Williford WO. Does perioperative total parenteral nutrition reduce medical care costs?. J Parent Ent Nutr 1993; 17: 201–9.

    CAS  Google Scholar 

  195. Galandiuk S, O’Neill M, McDonald P, Fazio VW, Steiger E. A century of home parenteral nutrition for Crohn’s disease. Am J Surg 1990; 159: 540–4.

    PubMed  CAS  Google Scholar 

  196. Gonzalez-Huix F, de Leon R, Fernandez-Banares F et al. Polymeric enteral diets as primary treatment of active Crohn’s disease: a prospective steroid controlled trial. Gut 1993; 34: 778–82.

    PubMed  CAS  Google Scholar 

  197. Teahon K, Bjarnason I, Pearson M, Levi AJ. Ten years’ experience with an elemental diet in the management of Crohn’s disease. Gut 1990; 31: 1133–7.

    PubMed  CAS  Google Scholar 

  198. Giaffer MH, North G, Holdsworth CD. Controlled trial of polymeric versus elemental diet in treatment of active Crohn’s disease. Lancet 1990; 335: 816–19.

    PubMed  CAS  Google Scholar 

  199. Gonzalez-Huix F, Fernandez-Banares F, Esteve-Comas M et al. Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis. Am J Gastroenterol 1993; 88: 227–32.

    PubMed  CAS  Google Scholar 

  200. Jones VA. Comparison of total parenteral nutrition and elemental diet in induction of remission of Crohn’s disease. Long-term maintenance of remission by personalized food exclusion diets. Dig Dis Sci 1987; 32: 100S–7S.

    PubMed  CAS  Google Scholar 

  201. Fernandez-Banares F, Cabre E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn’s disease? A meta-analysis of the randomized clinical trials. J Parent Ent Nutr 1995; 19: 356–64.

    CAS  Google Scholar 

  202. Gorard DA, Hunt JB, Payne-James JJ et al. Initial response and subsequent course of Crohn’s disease treated with elemental diet or prednisolone. Gut 1993; 34: 1198–202.

    PubMed  CAS  Google Scholar 

  203. Lindor KD, Fleming CR, Burnes JU, Nelson JK, Ilstrup DM. A randomized prospective trial comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn’s disease. Mayo Clin Proc 1992; 67: 328–33.

    PubMed  CAS  Google Scholar 

  204. Messori A, Trallori G, D’Albasio G, Milla M, Vannozzi G, Pacini F. Defined-formula diets versus steroids in the treat ment of active Crohn’s disease: a meta-analysis. Scand J Gastroenterol 1996; 31: 267–72.

    PubMed  CAS  Google Scholar 

  205. Okada M, Yao T, Yamamoto T, Takenaka K, Imamura K, Maeda K et al. Controlled trial comparing an elemental diet with prednisolone in the treatment of active Crohn’s disease. Hepato-Gastroenterology 1990; 37: 72–80.

    PubMed  CAS  Google Scholar 

  206. Zoli G, Care M, Parazza M et al. A randomized controlled study comparing elemental diet and steroid treatment in Crohn’s disease. Alimen Pharmacol Ther 1997; 11: 735–40.

    CAS  Google Scholar 

  207. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn’s disease. Gastroenterology 1995; 108: 1056–67.

    PubMed  CAS  Google Scholar 

  208. O’Brien CJ, Giaffer MH, Cann PA, Holdsworth CD. Elemental diet in steroid-dependent and steroid-refractory Crohn’s disease. Am J Gastroenterol 1991; 86: 1614–18.

    PubMed  CAS  Google Scholar 

  209. Abad-Lacruz A, Gonzalez-Huix F, Esteve M et al. Liver function tests abnormalities in patients with inflammatory bowel disease receiving artificial nutrition: a prospective randomized study of total enteral nutrition vs total parenteral nutrition. J Parent Ent Nutr 1990; 14: 618–21.

    CAS  Google Scholar 

  210. Cosgrove M, Jenkins HR. Experience of percutaneous endoscopic gastrostomy in children with Crohn’s disease. Arch Dis Childh 1997; 76: 141–3.

    PubMed  CAS  Google Scholar 

  211. di Costanzo J, Cano N, Martin J et al. Treatment of external gastrointestinal fistulas by a combination of total parenteral nutrition and somatostatin. J Parent Ent Nutr 1987; 11: 465–70.

    Google Scholar 

  212. Fernandez-Banares F, Mingorance MD, Esteve M, et al. Serum zinc, copper, and selenium levels in inflammatory bowel disease: effect of total enteral nutrition on trace element status. Am J Gastroenterol 1990; 85: 1584–9.

    PubMed  CAS  Google Scholar 

  213. Goode HF, Robertson DA, Kelleher J, Walker BE. Effect of fasting, self-selected and isocaloric glucose and fat meals and intravenous feeding on plasma zinc concentrations. Ann Clin Biochem 1991; 28 (Pt 5): 442–5.

    PubMed  Google Scholar 

  214. Myung SJ, Yang SK, Jung HY et al. Zinc deficiency manifested by dermatitis and visual dysfunction in a patient with Crohn’s disease. J Gastroenterol 1998; 33: 876–9.

    PubMed  CAS  Google Scholar 

  215. Rannem T, Ladefoged K, Hylander E, Hegnhoj J, Staun M. Selenium depletion in patients with gastrointestinal diseases: are there any predictive factors? Scand J Gastroenterol 1998; 33: 1057–61.

    PubMed  CAS  Google Scholar 

  216. Tominaga M, Iida M, Aoyagi K, Kohrogi N, Matsui T, Fujishima M. Red cell folate concentrations in patients with Crohn’s disease on parenteral nutrition. Postgrad Med J 1989; 65: 818–20.

    PubMed  CAS  Google Scholar 

  217. Touloukian RJ, Gertner JM. Vitamin D deficiency rickets as a late complication of the short gut syndrome during infancy. J Pediatr Surg 1981; 16: 230–5.

    PubMed  CAS  Google Scholar 

  218. Zak J, Burns D, Lingenfelser T, Steyn E, Marks IN. Dry beriberi: unusual complication of prolonged parenteral nutrition. J Parent Ent Nutr 1991; 15: 200–1.

    Google Scholar 

  219. Riordan AM, Hunter JO, Cowan RE et al. Treatment of active Crohn’s disease by exclusion diet: East Anglian multicentre controlled trial. Lancet 1993; 342: 1131–4.

    PubMed  CAS  Google Scholar 

  220. Lykins TC, Stockwell J. Comprehensive modified diet simplifies nutrition management of adults with short-bowel syndrome. J Am Diet Assoc 1998; 98: 309–15.

    PubMed  CAS  Google Scholar 

  221. Holman RT. Control of polyunsaturated acids in tissue lipids. J Am Coll Nutr 1986; 5: 183–211.

    PubMed  CAS  Google Scholar 

  222. Gerster H. Can adults adequately convert alpha-linolenic acid (18: 3n-3) to eicosapentaenoic acid (20: 5n-3) and docosahexaenoic acid (22: 6n-3)?. Int J Vit Nutr Res 1998; 68: 159–73.

    CAS  Google Scholar 

  223. Spector AA. Essentiality of fatty acids. Lipids 1999; 34(Suppl): S1–3.

    PubMed  CAS  Google Scholar 

  224. Fisher M, Upchurch KS, Levine PH et al. Effects of dietary fish oil supplementation on polymorphonuclear leukocyte inflammatory potential. Inflammation 1986; 10: 387–92.

    PubMed  CAS  Google Scholar 

  225. McCall TB, O’Leary D, Bloomfield J, O’Morain CA. Therapeutic potential of fish oil in the treatment of ulcerative colitis. Aliment Pharmacol Ther 1989; 3: 415–24.

    Article  PubMed  CAS  Google Scholar 

  226. Kuroki F, Iida M, Matsumoto T, Aoyagi K, Kanamoto K, Fujishima M. Serum n3 polyunsaturated fatty acids are depleted in Crohn’s disease. Dig Dis Sci 1997; 42: 1137–41.

    PubMed  CAS  Google Scholar 

  227. Geerling BJ, Houwelingen AC, Badart-Smook A, Stock-brugger RW, Brummer, RJ. Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn’s disease, compared with controls. Am J Gastroenterol 1999; 94: 410–17.

    Article  PubMed  CAS  Google Scholar 

  228. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. N Engl J Med 1996; 334: 1557–60.

    PubMed  CAS  Google Scholar 

  229. Belluzzi A, Campieri M, Brignola C, Gionchetti P, Miglioli M, Barbara L. Polyunsaturated fatty acid pattern and fish oil treatment in inflammatory bowel disease [Letter]. Gut 1993; 34: 1289–90.

    PubMed  CAS  Google Scholar 

  230. Hawthorne AB, Daneshmend TK, Hawkey CJ et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 1992; 33: 922–8.

    PubMed  CAS  Google Scholar 

  231. Almallah YZ, Richardson S, O’Hanrahan T et al. Distal procto-colitis, natural cytotoxicity, and essential fatty acids. Am J Gastroenterol 1998; 93: 804–9.

    PubMed  CAS  Google Scholar 

  232. Greenfield SM, Green AT, Teare JP et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther 1993; 7: 159–66.

    Article  PubMed  CAS  Google Scholar 

  233. Lee TH, Hoover RL, Williams JD et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985; 312:1217–24.

    Article  PubMed  CAS  Google Scholar 

  234. Matthews DE, Marano MA, Campbell RG. Splanchnic bed utilization of glutamine and glutamic acid in humans. Am J Physiol 1993; 264: E848–54.

    PubMed  CAS  Google Scholar 

  235. Reeds PJ, Burrin DG, Jahoor F et al. Enteral glutamate is almost completely metabolized in first pass by the gastro-intestinal tract of infant pigs [Published errata appear in Am J Physiol 1996; 271: section E following table of contents]. Am J Physiol 1996; 270: E413–18.

    PubMed  CAS  Google Scholar 

  236. Den Hond E, Hiele M, Peeters M, Ghoos Y, Rutgeerts P. Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn’s disease. J Parent Ent Nutr 1999; 23: 7–11.

    Google Scholar 

  237. Byrne TA, Morrissey TB, Gatzen C et al. Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation. Ann Surg 1993; 218: 400–16.

    PubMed  CAS  Google Scholar 

  238. Byrne TA, Morrissey TB, Nattakom TV, Ziegler TR, Wilmore DW. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. J Parent Ent Nutr 1995; 19: 296–302.

    Article  CAS  Google Scholar 

  239. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore, DW. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 1995; 222: 243–54.

    PubMed  CAS  Google Scholar 

  240. Scolapio JS, Camilleri M, Fleming CR et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997; 113: 1074–81.

    PubMed  CAS  Google Scholar 

  241. Wilmore DW, Lacey JM, Soultanakis RP, Bosch RL, Byrne, TA. Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg 1997; 226: 288–92.

    PubMed  CAS  Google Scholar 

  242. Lin HC, Van Citters GW, Heimer F, Bonorris G. Slowing of gastrointestinal transit by oleic acid: a preliminary report of a novel, nutrient-based treatment in humans. Dig Dis Sci 2001; 46: 223–9.

    PubMed  CAS  Google Scholar 

  243. Van Citters GW, Lin HC. Oleic acid improves drug absorption in patients with inflammatory bowel disease. Gastroenterology 1998; 114: A1105 (Abstract).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gonda Diabetes Research Center, City of Hope National Medical Center/Beckman Research Institute, Duarte, CA, USA

    Gregg W. Van Citters (Research Fellow)

  2. GI Motility Program and Section of Nutrition, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Henry C. Lin (Director, Associate Professor of Medicine)

  3. UCLA, Los Angeles, CA, USA

    Henry C. Lin (Director, Associate Professor of Medicine)

Authors
  1. Gregg W. Van Citters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Henry C. Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cedars-Sinai IBD Center, Los Angeles, CA, USA

    Stephan R. Targan  & Loren C. Karp  & 

  2. Cork University Hospital, Cork, Ireland

    Fergus Shanahan

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Kluwer Academic Publishers

About this chapter

Cite this chapter

Van Citters, G.W., Lin, H.C. (2003). Nutrition in inflammatory bowel disease. In: Targan, S.R., Shanahan, F., Karp, L.C. (eds) Inflammatory Bowel Disease: From Bench to Bedside. Springer, Boston, MA. https://doi.org/10.1007/0-387-25808-6_29

Download citation

  • DOI: https://doi.org/10.1007/0-387-25808-6_29

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-25807-2

  • Online ISBN: 978-0-387-25808-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation